東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Chromatin Regulators of MYC Oncoprot...

Tu, William Bo Chen.

Linked to FindBook

Google Book

Amazon

博客來

Chromatin Regulators of MYC Oncoprotein Activity in Cancer.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Chromatin Regulators of MYC Oncoprotein Activity in Cancer./
Author:	Tu, William Bo Chen.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2017,
Description:	233 p.
Notes:	Source: Dissertation Abstracts International, Volume: 79-07(E), Section: B.
Contained By:	Dissertation Abstracts International79-07B(E).
Subject:	Molecular biology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10289752
ISBN:	9780355537215

Chromatin Regulators of MYC Oncoprotein Activity in Cancer.
Tu, William Bo Chen.

Chromatin Regulators of MYC Oncoprotein Activity in Cancer. - Ann Arbor : ProQuest Dissertations & Theses, 2017 - 233 p.

Source: Dissertation Abstracts International, Volume: 79-07(E), Section: B.

Thesis (Ph.D.)--University of Toronto (Canada), 2017.

This item is not available from ProQuest Dissertations & Theses.

The MYC oncoprotein is a key contributor to the development of virtually all cancer types. MYC is known as a global regulator of transcription that controls diverse physiological and oncogenic functions. Though there are 35 years' worth of research on this protein, mechanistic understanding and therapeutic targeting of MYC are still needed. We hypothesize that chromatin interactors are critical for MYC to achieve transcriptional control and biological outcomes. Our proteomic study of the MYC interactome yielded chromatin complexes and epigenetic regulators. In this thesis, we investigated two MYC-interacting complexes and defined the chromatin landscape of the MYC interactome. We characterized the novel interaction of MYC and the G9a histone methyltransferase and demonstrated their coordinated regulation of genome-wide transcriptional repression. This interaction and their resulting gene expression output support breast cancer growth, which is impaired with G9a inhibition. This study underscores the crucial role of epigenetics and epigenetic regulators in modulating MYC activity; this serves as the basis for a compelling strategy to target oncogenic MYC. We also interrogated the interaction of MYC and the SWI/SNF chromatin remodeling complex, whose many components are inactivated in a multitude of cancer types. We specifically showed the direct interaction of MYC and the INI1 subunit and their antagonistic relationship in regulating transcription and biological functions. Combining our proteomic approach with genome-wide resources, we established the chromatin landscape of the MYC interactome, defining chromatin profiles and target gene networks of known and novel MYC interactors. Collectively, these studies brought new insights to the understanding of MYC through the identification of novel chromatin interactors of MYC, their coordinated roles in regulating transcriptional activation and repression, their contributions to MYC-driven oncogenesis, and their therapeutic potential.

ISBN: 9780355537215Subjects--Topical Terms:

517296
Molecular biology.

Chromatin Regulators of MYC Oncoprotein Activity in Cancer.
LDR:03052nmm a2200325 4500 001 2164117
005 20181030085011.5
008 190424s2017 ||||||||||||||||| ||eng d
020 $a 9780355537215
035 $a (MiAaPQ)AAI10289752
035 $a (MiAaPQ)toronto:15769
035 $a AAI10289752
040 $a MiAaPQ $c MiAaPQ
100 1 $a Tu, William Bo Chen. $3 3352153
245 1 0 $a Chromatin Regulators of MYC Oncoprotein Activity in Cancer.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2017
300 $a 233 p.
500 $a Source: Dissertation Abstracts International, Volume: 79-07(E), Section: B.
500 $a Adviser: Linda Z. Penn.
502 $a Thesis (Ph.D.)--University of Toronto (Canada), 2017.
506 $a This item is not available from ProQuest Dissertations & Theses.
520 $a The MYC oncoprotein is a key contributor to the development of virtually all cancer types. MYC is known as a global regulator of transcription that controls diverse physiological and oncogenic functions. Though there are 35 years' worth of research on this protein, mechanistic understanding and therapeutic targeting of MYC are still needed. We hypothesize that chromatin interactors are critical for MYC to achieve transcriptional control and biological outcomes. Our proteomic study of the MYC interactome yielded chromatin complexes and epigenetic regulators. In this thesis, we investigated two MYC-interacting complexes and defined the chromatin landscape of the MYC interactome. We characterized the novel interaction of MYC and the G9a histone methyltransferase and demonstrated their coordinated regulation of genome-wide transcriptional repression. This interaction and their resulting gene expression output support breast cancer growth, which is impaired with G9a inhibition. This study underscores the crucial role of epigenetics and epigenetic regulators in modulating MYC activity; this serves as the basis for a compelling strategy to target oncogenic MYC. We also interrogated the interaction of MYC and the SWI/SNF chromatin remodeling complex, whose many components are inactivated in a multitude of cancer types. We specifically showed the direct interaction of MYC and the INI1 subunit and their antagonistic relationship in regulating transcription and biological functions. Combining our proteomic approach with genome-wide resources, we established the chromatin landscape of the MYC interactome, defining chromatin profiles and target gene networks of known and novel MYC interactors. Collectively, these studies brought new insights to the understanding of MYC through the identification of novel chromatin interactors of MYC, their coordinated roles in regulating transcriptional activation and repression, their contributions to MYC-driven oncogenesis, and their therapeutic potential.
590 $a School code: 0779.
650 4 $a Molecular biology. $3 517296
650 4 $a Oncology. $3 751006
650 4 $a Cellular biology. $3 3172791
690 $a 0307
690 $a 0992
690 $a 0379
710 2 $a University of Toronto (Canada). $b Medical Biophysics. $3 3181600
773 0 $t Dissertation Abstracts International $g 79-07B(E).
790 $a 0779
791 $a Ph.D.
792 $a 2017
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10289752